Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Rebates and other sales deductions	$ 342,717	$ 325,711
Employee compensation and benefits	153,133	121,209
Clinical trial accruals	49,962	44,757
Accrued interest	41,626	36,443
Accrued royalties	36,802	30,706
Accrued milestones	27,500	0
Selling and marketing accruals	26,981	14,743
Sales return reserve	26,428	20,435
Consulting and professional services	26,221	19,538
Inventory-related accruals	25,509	13,977
Accrued development expenses	23,099	15,431
Accrued collaboration expenses	18,005	10,158
Current portion of lease liabilities	14,779	19,447
Derivative instrument liabilities	10,198	681
Accrued construction-in-progress	10,061	5,141
Accrued facilities expenses	6,107	55,455
Other	71,819	60,082
Accrued liabilities	$ 910,947	$ 793,914